Elevated intraocular pressure (IOP) is a major risk factor for
|
|
- Diane Walker
- 5 years ago
- Views:
Transcription
1 Glaucoma Twenty-Four Hour Pattern of Intraocular Pressure in Untreated Patients with Ocular Hypertension Tomas M. Grippo, 1,2 John H. K. Liu, 1 Nazlee Zebardast, 2 Taylor B. Arnold, 3 Grant H. Moore, 1 and Robert N. Weinreb 1 PURPOSE. To characterize the 24-hour pattern of intraocular pressure (IOP) in untreated ocular hypertensive (OHTN) patients. METHODS. IOP measurements were taken every 2 hours during a 24-hour period from 15 untreated OHTN patients (ages years). Measurements were both sitting and supine (diurnal) and supine only (nocturnal). Mean diurnal and nocturnal IOPs in the OHTN group were compared to previously reported values in age-matched healthy and glaucomatous eyes. Post hoc analysis compared the 24-hour IOP pattern of the OHTN patients who converted to glaucoma and those who did not with that in the same healthy and glaucomatous eyes. RESULTS. Mean sitting and supine IOPs were significantly higher in the OHTN group than in the healthy control but not the glaucoma group. Similar to the glaucoma group, the OHTN group demonstrated significant differences from healthy controls in diurnal IOP variation and IOP changes upon awakening in habitual and supine positions. The 24-hour IOP curve acrophases and amplitudes for OHTNs were closer to those of the glaucoma than the healthy control group in the habitual position. Thirty-three percent of OHTNs developed glaucoma during a mean follow-up period of years. Similar to findings in the glaucoma group, habitual IOP curve phase delay, habitual IOP variation, diurnal-to-nocturnal IOP changes, and IOP changes upon awakening of the converters were significantly different from those in healthy controls. There were no differences between nonconverters and other groups. CONCLUSIONS. Baseline 24-hour IOP pattern in OHTN patients is similar to that in glaucomatous patients. In contrast to nonconverters, OHTN patients who converted to glaucoma are significantly different from healthy controls. (Invest Ophthalmol Vis Sci. 2013;54: ) DOI: / iovs From the 1 Hamilton Glaucoma Center and Department of Ophthalmology, University of California at San Diego, La Jolla, California; the 2 Department of Ophthalmology, Yale School of Medicine, New Haven, Connecticut; and the 3 Department of Statistics, Yale University, New Haven, Connecticut. Supported in part by NIH Grant EY Submitted for publication August 4, 2012; revised October 28, 2012; accepted November 21, Disclosure: T.M. Grippo, None;J.H.K. Liu, None;N. Zebardast, None;T.B. Arnold, None;G.H. Moore, None;R.N. Weinreb, None Corresponding author: Tomas M. Grippo, Department of Ophthalmology, Yale School of Medicine, 40 Temple Street, New Haven, CT 06510; tomas.grippo@yale.edu. Elevated intraocular pressure (IOP) is a major risk factor for the development of glaucoma. Therapeutic strategies designed to reduce IOP remain the principal method of treatment. 1,2 In the United States, ocular hypertension (OHTN) has been estimated to affect approximately 5% of people over 40 years of age. 3 However, this large OHTN patient population remains poorly characterized in terms of the standard quantitative measure of IOP. Measurement of IOP, taken at a single time point during office hours, can render an incomplete picture of IOP due to the diurnal variability of IOP. 4 While the diurnal IOP curve provides a better estimate of an individual s IOP variation than a single office reading, 5 IOP data gathered over 24 hours are required to characterize IOP variation more completely Indeed, most patients peak IOPs have been reported outside of office hours. 11,12 The pattern of 24-hour IOP for patients with early glaucomatous changes and for healthy controls has been described, 7,10,11,13 but limited information is available about the 24-hour IOP variation in patients with OHTN. The goal of the present study was to characterize the 24- hour IOP profile associated with untreated OHTN and compare this to previously reported 24-hour IOP patterns associated with an age-matched control group of individuals with healthy eyes and an age-matched group of patients with early-stage primary open angle glaucoma (POAG). 7 To the best of our knowledge, this is the first study to compare the pattern of 24-hour IOP in patients with OHTN to both healthy controls and patients with early glaucomatous signs of visual field loss and/or optic nerve damage. METHODS Ethics Statement This study followed the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board at the University of California at San Diego (UCSD). Written informed consent was obtained from all patients after explanation of the nature and possible consequences of the study. Study Subjects Experimental subjects were recruited consecutively from patients referred to the Hamilton Glaucoma Center of UCSD with the diagnosis of OHTN in both eyes. Each patient underwent a complete ophthalmologic evaluation that included a review of relevant medical history, best corrected visual acuity, slit-lamp biomicroscopy, gonioscopy, Goldman applanation tonometry, dilated funduscopy, and visual field testing. Patients with IOP 21 mm Hg on two consecutive visits prior to the experiment were considered for inclusion in the study. Patients with abnormal or suspected abnormal optic discs or visual fields were excluded. Abnormal discs included excavation, rim defect, hemorrhage, notching, nerve fiber layer defect, or cup/disc asymmetry Investigative Ophthalmology & Visual Science, January 2013, Vol. 54, No Copyright 2013 The Association for Research in Vision and Ophthalmology, Inc.
2 IOVS, January 2013, Vol. 54, No Hour IOP Pattern in Ocular Hypertension 513 between two eyes 0.2. A normal visual field was determined by clinical review and by Statpac II criteria for abnormality (full-threshold 24-2 examination, Humphrey Field Analyzer; Zeiss-Humphrey, Dublin, CA). A visual field was considered within normal limits if the corrected pattern standard deviation had a P > 5% and the glaucoma hemifield test was within normal limits. Individuals with history of prior glaucoma medication use or laser trabeculoplasty, prior eye surgery, ocular inflammation or trauma, a narrow iridocorneal angle, or any other concomitant ocular conditions were excluded. Individuals who smoked or had an irregular daily sleep schedule were also excluded. Fifteen patients who met the criteria described were recruited as the OHTN group. This included 8 males and 7 females who were 41 to 77 years of age ( years, mean 6 SD). There were 13 Caucasians and 2 African Americans. Mean central corneal thickness (CCT) was lm (mean 6 SD). Twenty-Four Hour IOP Measurement Twenty-four hour IOP measurements for all three groups were conducted contemporaneously. The experimental procedure employed and data generated from healthy and glaucoma groups were previously described by Liu et al. 7 Briefly, experiments were conducted within a few weeks after recruitment. Subjects maintained a daily 8- hour sleep period for 7 days prior to the experiment. On the study day, they arrived at the laboratory at approximately 2 PM and stayed indoors for the next 24 hours. The 8-hour period of darkness in the subject s room and times for IOP measurements were adjusted to correspond to each individual s sleep period. Individualized corresponding clock times were subsequently normalized for data presentation as if each subject had a sleep period from 11 PM to 7 AM. Over the 24 hours, IOP was measured in both eyes every 2 hours using a pneumatonometer (Model 30 Classic; Reichert, Depew, NY). Topical 0.5% proparacaine was applied as the local anesthetic. The pneumatonometer was calibrated against the manufacturer s verifier, and it was confirmed that different measurement angles produced the same IOP reading. Before the sleep period, measurements were taken at 3:30 PM, 5:30 PM, 7:30 PM, and 9:30 PM. Diurnal IOPs were obtained in both the supine and sitting position following lying down in bed or sitting up for 5 minutes, respectively. Light intensity was kept at 500 to 1000 lux at eye level during this time. Lights in individual rooms were turned off at 11 PM. Nocturnal IOP measurements were taken in the supine position only at 11:30 PM, 1:30 AM, 3:30 AM, and 5:30 AM. If necessary, subjects were awakened briefly and a room light (less than 10 lux) was used to assist the nocturnal measurements. Daytime room lighting was restored at 7 AM, and diurnal IOP measurements were taken again at 7:30 AM, 9:30 AM, 11:30 AM, and 1:30 PM as previously described. Data and Statistical Analysis Sitting and supine IOP data obtained from the OHTN patient group were compared to contemporaneous data obtained under identical experimental conditions from an age-matched healthy control group of 10 males and 14 females ( years of age, mean 6 SD) and a glaucoma group of 11 males and 13 females ( years of age, mean 6 SD). The characteristics of these groups have been described in detail by Liu et al. 7 The CCT was lm and lm in the healthy control and glaucoma groups, respectively. For all patients, IOP values from the two eyes were averaged. For each group, mean IOPs were calculated for each time point and during the diurnal and nocturnal periods. IOP variation was calculated by subtracting the trough IOP from the peak IOP during each diurnal or nocturnal period for all patients. These differences were averaged within groups. Statistical comparisons of the means between the diurnal and the nocturnal periods or two time points (e.g., 5:30 AM and 7:30 AM) within a group were made using a paired two-tailed t-test. Statistical comparisons between the OHTN, glaucoma, and healthy control groups were performed using one-way analysis of variance FIGURE 1. A comparison of 24-hour IOP patterns for the OHTN (open circles), healthy control (open triangles), and glaucoma (solid squares) groups in the habitual position (diurnal sitting, nocturnal supine). The OHTN group consisted of 15 untreated 41- to 77-year-old patients with IOP > 21 mm Hg on two consecutive visits and no evidence of glaucomatous changes. This group was compared with an age-matched control group with healthy eyes (n ¼ 24) and an untreated glaucoma group (n ¼ 24). Error bars denote SEM. (ANOVA). If ANOVA yielded a significant result (P < 0.05), this was followed by two-tailed t-test for two-group comparisons. Estimation of 24-hour IOP rhythm was performed for habitual and supine body positions using best-fitting cosine curve. This was obtained for each subject using IOP data from the 12 time points. The peak of the curve (acrophase) represents the phase timing, while the amplitude (height of the curve) estimates magnitude of 24-hour IOP variation. The Rayleigh test was used to determine the presence of a significant synchronized 24-hour IOP rhythm in each group. 7 Twotailed t-test was used for statistical comparison of mean group acrophases and amplitudes. Appropriate Bonferroni corrections were applied to all P values. All data are presented as mean 6 SEM unless otherwise specified. RESULTS No significant difference was found in age among the three groups (ANOVA P ¼ 0.39). However, there was a significant difference in CCT (ANOVA P ¼ 0.02), with the OHTN group significantly higher than the healthy control (P ¼ 0.012) but not the glaucoma group. There was no significant correlation of CCT with mean diurnal supine, diurnal sitting, and nocturnal IOPs (P ¼ 0.88, 0.40, 0.20, respectively) in the OHTN group. Figure 1 shows the 24-hour IOP patterns for the three subject groups in the habitual position (diurnal sitting, nocturnal supine), while Figure 2 shows the 24-hour IOP pattern for the supine position (diurnal supine, nocturnal supine). Sitting and supine IOPs at all time points were higher in the OHTN group compared to both the glaucoma and healthy control groups. In the OHTN group, similar to the other two groups, sitting and supine IOPs decreased progressively in the diurnal period while IOP increased during the nocturnal period. In the habitual position, the IOP peak occurred between 1:30 AM and 3:30 AM in the OHTN group (24.5 mm Hg) but at 5:30 AM in both the glaucoma and healthy control groups (22.6 and 22.5 mm Hg, respectively). The trough occurred at 9:30 PM for all three groups (18.7, 17.8, and 14.9 mm Hg for OHTN, glaucoma, and healthy control groups, respectively). In the supine position, the peak IOP occurred at 3:30 PM in the OHTN group (25.4 mm Hg), at 7:30 AM in the glaucoma group (24.5 mm Hg), and at 5:30 AM in the healthy
3 514 Grippo et al. IOVS, January 2013, Vol. 54, No. 1 TABLE 2. Diurnal and Nocturnal IOP Variation in mm Hg (Peak IOP Trough IOP) Diurnal Sitting Diurnal Supine Nocturnal Supine Healthy control Glaucoma OHTN Data expressed as the mean 6 SEM; N ¼ 15 (OHTN group), 24 (healthy control group), and 24 (glaucoma group). FIGURE 2. A comparison of 24-hour IOP patterns for the OHTN (open circles), healthy control (open triangles), and glaucoma (solid squares) groups in the supine position (diurnal supine, nocturnal supine). Error bars denote SEM. control group (22.5 mm Hg). The trough occurred at 9:30 PM for all three groups (22.3, 21.4, and 19.2 mm Hg for OHTN, glaucoma, and healthy control groups, respectively). The mean diurnal and nocturnal IOPs for each group are summarized in Table 1. The mean diurnal and nocturnal IOPs were significantly higher in the OHTN group compared to the healthy control group (P < 0.001, P < 0.001, P ¼ for diurnal sitting, diurnal supine, and nocturnal IOP, respectively; ANOVA P < 0.001) but not the glaucoma group. In the habitual position for all three groups, the mean nocturnal IOP was significantly higher than their diurnal IOP (P ¼ 0.003, P < 0.001, P < for OHTN, glaucoma, and healthy controls, respectively). The diurnal-to-nocturnal change in IOP in the habitual position was smaller in both the OHTN and glaucoma groups compared to the control group. In the supine position, the nocturnal compared to the diurnal IOP decreased in both the OHTN and glaucoma groups while it increased in the healthy control group. Significant differences in diurnal variation in both sitting (ANOVA P ¼ ) and supine (ANOVA P ¼ ) IOP were observed between groups. Diurnal IOP variation (Table 2) in both the OHTN (diurnal sitting and supine P ¼ and 0.021, respectively) and glaucoma (diurnal sitting and supine P ¼ and 0.039, respectively) groups was significantly higher than that of the healthy control group. In the nocturnal period, no significant differences in supine IOP variation between the three groups were observed (ANOVA P ¼ 0.46). Table 3 summarizes changes in IOP upon awakening (5:30 AM 7:30 AM). In the habitual position, the IOP decreased for all groups upon awakening. This decrease was significantly smaller in both the OHTN and glaucoma groups compared to the healthy control group (P ¼ and P ¼ 0.012, respectively). In the supine position, the IOP increased on awakening in the OHTN and glaucoma group while it decreased in the healthy control group. This IOP change in both the OHTN and glaucoma groups was significantly different from that in the healthy control group (P ¼ and P ¼ 0.006, respectively). Figure 3 shows the clock hour of acrophases with amplitudes in radial scale for all three groups in the habitual (Fig. 3A) and supine (Fig. 3B) positions obtained from bestfitted cosine curve estimation of 24-hour IOP rhythm. In the habitual position, the Rayleigh test detected a 24-hour IOP rhythm in all subject groups (P < 0.001, P < , P < for the OHTN, glaucoma, and healthy control groups, respectively). The acrophase occurred at 5:34 AM hours in the OHTN group. This was closer to the time for the glaucoma group (5:16 AM hours) than for the healthy control group (3:49 AM hours). The amplitude in the OHTN group was mm Hg, which was again closer to that of the glaucoma group ( mm Hg) compared to healthy controls ( mm Hg). In the supine position, there was a 24-hour rhythm in the healthy control (P ¼ 0.003) and glaucoma (P ¼ 0.001) groups but not the OHTN group (P ¼ 0.42). We had the opportunity to follow the clinical evolution of these OHTN patients and found that 5 of the 15 patients (33%) eventually developed glaucoma per clinical criteria previously outlined. 7 The mean follow-up period for this group was years, while the average time to conversion was years. Following baseline measurements of 24-hour IOP patterns, all OHTN patients were treated as deemed necessary by the attending glaucoma specialist. During the follow-up period, patients who converted to glaucoma were on average treated with a larger number of pressure-lowering eye drops and were more likely to have received laser trabeculoplasty TABLE 1. Mean Diurnal and Nocturnal IOP Diurnal Period (7 AM 11 PM) Nocturnal Period (11 PM 7 AM) Change TABLE 3. IOP Changes upon Awakening 5:30 AM 7:30 AM Change Habitual IOP, mm Hg Healthy control * Glaucoma * OHTN Supine IOP, mm Hg Healthy control Glaucoma OHTN Data expressed as the mean 6 SEM; N ¼ 15 (OHTN group), 24 (healthy control group), and 24 (glaucoma group). *P < 0.01 and P < 0.05; paired t-test between diurnal and nocturnal IOPs. Habitual IOP, mm Hg Healthy control * Glaucoma OHTN Supine IOP, mm Hg Healthy control Glaucoma OHTN Data expressed as the mean 6 SEM; N ¼ 15 (OHTN group), 24 (healthy control group), and 24 (glaucoma group). *P < 0.01 and P < 0.05; paired t-test 5:30 AM and 7:30 AM IOPs.
4 IOVS, January 2013, Vol. 54, No Hour IOP Pattern in Ocular Hypertension 515 FIGURE 3. Estimated 24-hour rhythm of IOP in habitual (A) and supine (B) body positions. The clock time of acrophase with the corresponding amplitude on the radial scale is shown for OHTN (open circles), healthy control (open triangles), and glaucoma (solid squares) groups. compared to nonconverters ( drops and drops, respectively, P ¼ 0.02; 60% and 10% trabeculoplasty, respectively). One patient in each group had cataract extraction during this period. We performed a post hoc analysis of the baseline data from this small subset of patients. Figure 4 shows the 24-hour IOP patterns for the converter andnonconvertergroupsin the habitual position while Figure 5 shows the 24-hour IOP pattern for the supine position. All data are summarized in Table 4. In this converter group in the habitual position, the mean nocturnal IOP was significantly higher than their diurnal IOP (P ¼ 0.02). This diurnal-to-nocturnal change in IOP was significantly smaller than in the healthy control group (P ¼ 0.004) but not the glaucoma group. In the supine position, the nocturnal IOP decreased compared to the diurnal IOP. This decrease was again significantly different between the converter and the healthy control group (P ¼ 0.004) but not the glaucoma group. Similarly to the glaucoma group, upon awakening, the IOP decreased in the habitual position and increased in the supine position in the converter group. These changes in IOP upon awaking were significantly different between the converter and healthy control groups only (P ¼ 0.004, P ¼ 0.012, habitual and supine positions, respectively). No significant differences were detected between the nonconverters and the glaucoma or healthy control groups. In the habitual position, the Rayleigh test detected a 24- hour IOP rhythm for the nonconverter (P < 0.001) but not the converter group. The acrophase occurred at 7:29 AM hours and at 4:37 AM hours in the converter and nonconverter groups, respectively. The amplitude was mm Hg in the converter group and in the nonconverter group. The acrophase and amplitude were significantly different between the converter and healthy control (P < and P < 0.001, respectively) groups only. In the supine position, the Rayleigh test did not detect a 24- hour IOP rhythm in either the converter or nonconverter group. DISCUSSION To our knowledge, this is the first study reporting the 24-hour IOP pattern in patients with OHTN. In the habitual and supine positions, the general IOP pattern for the OHTN group closely resembled the pattern previously described for both healthy subjects and glaucoma patients. 7 Similar to the current data, FIGURE 4. Twenty-four hour IOP patterns for the OHTN patients who converted to glaucoma (converters, n ¼ 5; dotted line, solid circles) and those who did not (nonconverters, n ¼ 10; dashed line, open circles) in the habitual position (diurnal sitting, nocturnal supine). Healthy control (n ¼ 24; open triangles) and glaucoma (n ¼ 24; solid squares) groups are shown for comparison. FIGURE 5. Twenty-four hour IOP patterns for the converter (n ¼ 5; dotted line, solid circles) and nonconverter (n ¼ 10; dashed line, open circles) groups in the supine position (diurnal supine, nocturnal supine). Healthy control (n ¼ 24; open triangles) and glaucoma (n ¼ 24; solid squares) groups are shown for comparison.
5 516 Grippo et al. IOVS, January 2013, Vol. 54, No. 1 TABLE 4. IOP Parameters for the OHTN Patients Who Converted to Glaucoma (Converters) and Those Who Did Not (Nonconverters) Converters Nonconverters Mean IOP, mm Hg Diurnal sitting Nocturnal supine Diurnal supine IOP change on awakening Habitual, mm Hg 5:30 AM :30 AM Supine, mm Hg 5:30 AM :30 AM Habitual IOP, mm Hg Peak 24 (5:30 AM) 25.1 (3:30 AM) Trough 19.6 (9:30 PM) 18.3 (9:30 PM) Supine IOP, mm Hg Peak 28 (3:30 PM) 25.1 (3:30 AM) Trough 22.8 (9:30 PM) 22 (9:30 PM) IOP variation, mm Hg Diurnal sitting Diurnal supine Nocturnal supine Data expressed as the mean 6 SEM; N ¼ 5 (converter group) and 10 (nonconverter group). the 24-hour IOP rhythm that describes an early morning peak decreasing over the day to an evening trough has also been described previously by De Vivero et al. 14 and, more recently, by Lee et al. 15 in patients with normal-tension glaucoma. Our habitual diurnal data agree well with those reported by David et al. 5 showing that the diurnal IOP levels gradually declined throughout the day from 7:45 AM to 7 PM. Even though the IOP rhythm in the OHTN group is similar to that of the healthy control and glaucoma groups, the peak IOP occurred at different times compared to these groups, suggesting a phase shift in the OHTN IOP curve. In the habitual position, the IOP peak in OHTN patients occurred in the nocturnal period; in the supine position, the peak IOP occurred mid-afternoon in this group. This contrasts considerably with what is observed in glaucoma patients and healthy control subjects. The mechanism for this remains unknown and warrants further investigation. In both the habitual and supine positions, however, the trough IOP occurred at 9:30 PM, which is in agreement with data previously reported for healthy control and glaucoma groups. 11 The current results suggest that the general 24-hour IOP pattern in patients with OHTN is similar to that of patients with POAG. The OHTN and glaucoma groups both demonstrated higher diurnal mean IOPs as well as greater diurnal IOP variation (maximum minimum) compared to healthy controls. In addition, the variation in 24-hour IOP (amplitude of fitted cosine curve) in the habitual position was lower in both the OHTN and glaucoma groups compared to healthy controls. The OHTN and glaucoma groups also demonstrated similar phase delays in 24-hour IOP rhythms for the habitual position. This suggests a similar endogenous mechanism in OHTN and glaucoma. In the healthy control group, we observed a greater nocturnal increase in mean IOP and a greater decrease in the IOP upon awakening (between 5:30 and 7:30 AM) in the habitual position compared to the supine position. Together, this suggests the effect of posture on IOP as described by Hara et al. 16 In the habitual position, this diurnal-to-nocturnal change in mean IOP as well as the IOP decrease upon awakening was smaller in the OHTN and glaucoma groups. Possible explanations for these findings could be yet uncharacterized differences in postural regulation of IOP or simply higher daytime and nighttime IOPs in these groups. Accordingly, Liu et al. and Fan et al. have reported daytime versus nighttime differences in aqueous humor dynamics between OHTN and normotensive subjects, 17,18 with significant reductions in nighttime outflow facility in normotensive but not OHTN subjects. This, in addition to the already low daytime outflow facility in OHTN patients, 19 may partially explain the above findings. When we excluded the effect of posture, we found that the mean IOP levels changed in opposing directions: increasing in healthy controls and decreasing in the OHTN and glaucoma groups. Similarly, at awakening, we observed a decrease in the healthy control group but an increase in IOP in the OHTN and glaucoma groups. This suggests that regulation of IOP may be different in the OHTN and glaucoma groups compared to healthy controls. As previously suggested by Liu et al., 7 these observations may reflect various endogenous mechanisms yet to be identified that may be responsible for the IOP pattern in ocular hypertensives. One possibility is that early dysfunction in the trabecular meshwork in patients with OHTN, 19 and the resultant reduction in pressure-sensitive aqueous outflow in addition to the increased diurnal aqueous production, 20 may partially explain our findings. In this study, we also examined serial testing data that we had collected over several years to follow the progression of our OHTN patients. The patients were divided into two subgroups: a population that did not progress to glaucoma (nonconverters, 10/15) and a population that did progress to glaucoma (converters, 5/15). Such data may address whether the 24-hour IOP pattern in the OHTN group is of use in providing additional insight into risk stratification of patients with OHTN. Our analysis revealed that the converter group demonstrated an IOP pattern very similar to that of the glaucoma group compared to the healthy controls. The converter and glaucoma groups demonstrated similar patterns of diurnal-to-nocturnal changes in IOP and IOP changes upon awaking in the habitual and supine positions. These findings must be interpreted in view of several limitations of the study. First, we detected no differences between the nonconverters and either the glaucoma patients or healthy control subjects. This inability to differentiate the nonconverters from other groups is likely due to the small number of patients and variability of the data in this heterogeneous population. As demonstrated in the Ocular Hypertensive Treatment Study, a minority of OHTN patients will develop glaucoma; the percentage of these patients increases over time. 3 This suggests that our nonconverter group may have contained both healthy individuals and individuals who may yet progress to glaucoma. Second, the presence of differences in CCT among the groups may have influenced our results. CCT is known to correlate positively with IOP and has been suggested as a risk factor in glaucoma development. 12 Weighing against this possibility, however, is the fact that we found no correlation between mean IOP measurements and CCT in the OHTN group, and the mean CCT did not differ between the converter and nonconverter subgroups (P > 0.8). Before more general recommendations can be made regarding the utility of the OHTN pattern in predicting progression, further study with a larger sample population is required. This might allow the differentiation of converter from nonconverter OHTN patients before they develop glaucoma for appropriate risk stratification and management.
6 IOVS, January 2013, Vol. 54, No Hour IOP Pattern in Ocular Hypertension 517 References 1. Mansouri K, Weinreb R. Continuous 24-hour intraocular pressure monitoring for glaucoma time for a paradigm change. Swiss Med Wkly. 2012;142:w Caprioli J, Varma R. Intraocular pressure: modulation as treatment for glaucoma. Am J Ophthalmol. 2011;152: , e Kass MA, Gordon MO, Gao F, et al. Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol. 2010;128: Barkana Y, Anis S, Liebmann J, Tello C, Ritch R. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol. 2006;124: David R, Zangwill L, Briscoe D, Dagan M, Yagev R, Yassur Y. Diurnal intraocular pressure variations: an analysis of 690 diurnal curves. Br J Ophthalmol. 1992;76: Hughes E, Spry P, Diamond J. 24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma. 2003;12: Liu JH, Zhang X, Kripke DF, Weinreb RN. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci. 2003;44: Nakakura S, Nomura Y, Ataka S, Shiraki K. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops. J Glaucoma. 2007;16: Sit AJ. Continuous monitoring of intraocular pressure: rationale and progress toward a clinical device. J Glaucoma. 2009;18: Tajunisah I, Reddy SC, Fathilah J. Diurnal variation of intraocular pressure in suspected glaucoma patients and their outcome. Graefes Arch Clin Exp Ophthalmol. 2007;245: Mosaed S, Liu JH, Weinreb RN. Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients. Am J Ophthalmol. 2005;139: Mosaed S, Chamberlain WD, Liu JH, Medeiros FA, Weinreb RN. Association of central corneal thickness and 24-hour intraocular pressure fluctuation. J Glaucoma. 2008;17: Buguet A, Py P, Romanet JP. 24-hour (nyctohemeral) and sleeprelated variations of intraocular pressure in healthy white individuals. Am J Ophthalmol. 1994;117: De Vivero C, O Brien C, Lanigan L, Hitchings R. Diurnal intraocular pressure variation in low-tension glaucoma. Eye (Lond). 1994;8(pt 5): Lee YR, Kook MS, Joe SG, et al. Circadian (24-hour) pattern of intraocular pressure and visual field damage in eyes with normal-tension glaucoma. Invest Ophthalmol Vis Sci. 2012;53: Hara T, Hara T, Tsuru T. Increase of peak intraocular pressure during sleep in reproduced diurnal changes by posture. Arch Ophthalmol. 2006;124: Liu H, Fan S, Gulati V, et al. Aqueous humor dynamics during the day and night in healthy mature volunteers. Arch Ophthalmol. 2011;129: Fan S, Hejkal JJ, Gulati V, Galata S, Camras CB, Toris CB. Aqueous humor dynamics during the day and night in volunteers with ocular hypertension. Arch Ophthalmol. 2011;129: Toris CB, Koepsell SA, Yablonski ME, Camras CB. Aqueous humor dynamics in ocular hypertensive patients. J Glaucoma. 2002;11: Brubaker RF. Flow of aqueous humor in humans [The Friedenwald Lecture]. Invest Ophthalmol Vis Sci. 1991;32:
Role of Central Corneal Thickness in Circadian Intraocular Pressure Fluctuations among Patients with Primary Open Angle Glaucoma
Role of Central Corneal Thickness in Circadian Intraocular Pressure Fluctuations among Patients with Primary Open Angle Glaucoma Mohannad Albdour MD*, Karanjit Kooner MD, PHD** ABSTRACT Objectives: To
More informationIntraocular pressure (IOP) is the main risk factor for the
The Circadian Curve of Intraocular Pressure: Can We Estimate Its Characteristics during Office Hours? Paolo Fogagnolo, 1 Nicola Orzalesi, 2 Antonio Ferreras, 3,4 and Luca Rossetti 2 PURPOSE. To verify
More informationEffect of brimonidine on intraocular pressure in normal tension glaucoma: A short term clinical trial
European Journal of Ophthalmology / Vol. 13 no. 7, 2003 / pp. 611-615 Effect of brimonidine on intraocular pressure in normal tension glaucoma: A short term clinical trial S.A. GANDOLFI, L. CIMINO, P.
More information4/06/2013. Medication Observation POAG. Proportion. Native American 0.1% 0.4%
Clinical Research in Glaucoma: Putting Science into Practice J. James Thimons, O.D., FAAO Chairman, National Glaucoma Society www.nationalglaucomasociety.org Ocular Hypertension Treatment Study (OHTS)
More informationIntro to Glaucoma/2006
Intro to Glaucoma/2006 Managing Patients with Glaucoma is Exciting Interesting Challenging But can often be frustrating! Clinical Challenges To identify patients with risk factors for possible glaucoma.
More information24-hour IOP fluctuation: myth or reality?
Journal for Modeling in Ophthalmology 2016; 2:103-109 Review article 24-hour IOP fluctuation: myth or reality? Luciano Quaranta 1, Ivano Riva 1, Francesco Oddone 2 1 Department of Medical and Surgical
More informationPrevalence Of Primary Open Angle Glaucoma in Diabetic Patients
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 6 Ver. III (June. 2017), PP 147-151 www.iosrjournals.org Prevalence Of Primary Open Angle Glaucoma
More information53 year old woman attends your practice for routine exam. She has no past medical history or family history of note.
Case 1 Normal Tension Glaucoma 53 year old woman attends your practice for routine exam. She has no past medical history or family history of note. Table 1. Right Eye Left Eye Visual acuity 6/6 6/6 Ishihara
More informationOcular Hypotensive Efficacy of Netarsudil Ophthalmic Solution 0.02% Over a 24-Hour Period: A Pilot Study
Ocular Hypotensive Efficacy of Netarsudil Ophthalmic Solution 0.02% Over a 24-Hour Period: A Pilot Study James H. Peace, M.D. 1, Casey K. Kopczynski, Ph.D. 2, and Theresa Heah, M.D. 2 1 Inglewood, CA 2
More informationAcute Effects of Dexomethosone on Intraocular Pressure in Glaucoma
Acute Effects of Dexomethosone on Intraocular Pressure in Glaucoma Robert N. Weinreb,* Jon W. Polansky,* Steven G. Kramer,* and John D. Doxrerf The effects of mg orally administered dexamethasone on the
More informationStudy of Retinal Nerve Fiber Layer Thickness Within Normal Hemivisual Field in Primary Open-Angle Glaucoma and Normal-Tension Glaucoma
Study of Retinal Nerve Fiber Layer Thickness Within Normal Hemivisual Field in Primary Open-Angle Glaucoma and Normal-Tension Glaucoma Chiharu Matsumoto, Shiroaki Shirato, Mai Haneda, Hiroko Yamashiro
More informationSpontaneous Intraocular Pressure Reduction in Normal-Tension Glaucoma and Associated Clinical Factors
CLINICAL INVESTIGATIONS Spontaneous Intraocular Pressure Reduction in Normal-Tension Glaucoma and Associated Clinical Factors Akihiro Oguri, Tetsuya Yamamoto and Yoshiaki Kitazawa Department of Ophthalmology,
More informationThe Role of the RNFL in the Diagnosis of Glaucoma
Chapter 1. The Role of the RNFL in the Diagnosis of Glaucoma Introduction Glaucoma is an optic neuropathy characterized by a loss of of retinal ganglion cells and their axons, the Retinal Nerve Fiber Layer
More informationResearch Article Twenty-Four-Hour Variation of Intraocular Pressure in Primary Open-Angle Glaucoma Treated with Triple Eye Drops
Hindawi Ophthalmology Volume 2017, Article ID 4398494, 6 pages https://doi.org/10.15/2017/4398494 Research Article Twenty-Four-Hour Variation of Intraocular Pressure in Primary Open-Angle Glaucoma Treated
More informationSTANDARD AUTOMATED PERIMETRY IS A GENERALLY
Comparison of Long-term Variability for Standard and Short-wavelength Automated Perimetry in Stable Glaucoma Patients EYTAN Z. BLUMENTHAL, MD, PAMELA A. SAMPLE, PHD, LINDA ZANGWILL, PHD, ALEXANDER C. LEE,
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Conversion of Ocular Hypertensives into Glaucoma: A Retrospective Study Aditi Singh 1, Shibi
More informationIs NTG different from POAG?
Is NTG different from POAG? Sunita Radhakrishnan, M.D Glaucoma Center of San Francisco Glaucoma Research and Education Group Subset of POAG 1 Connective tissue structure within ONH Ganglion cell susceptibility
More informationThe Effect of Pupil Dilation on Scanning Laser Polarimetry With Variable Corneal Compensation
C L I N I C A L S C I E N C E The Effect of Pupil Dilation on Scanning Laser Polarimetry With Variable Corneal Compensation Amjad Horani, MD; Shahar Frenkel, MD, PhD; Eytan Z. Blumenthal, MD BACKGROUND
More informationCircadian Pattern of Intraocular Pressure Fluctuations in Young Myopic Eyes With Open-Angle Glaucoma
Glaucoma Circadian Pattern of Intraocular Pressure Fluctuations in Young Myopic Eyes With Open-Angle Glaucoma Da Woon Jeong, Michael S. Kook, Kyoung Sub Lee, Jong Rak Lee, and Seungbong Han Department
More informationSTRUCTURE & FUNCTION An Integrated Approach for the Detection and Follow-up of Glaucoma. Module 3a GDx
STRUCTURE & FUNCTION An Integrated Approach for the Detection and Follow-up of Glaucoma Module 3a GDx Educational Slide Deck Carl Zeiss Meditec, Inc. November 2005 1 Structure & Function Modules Module
More informationEarly Detection Of Glaucoma Clinical Clues. Points To Live By. Glaucoma Risk Factors 10/3/2014
Early Detection Of Glaucoma Clinical Clues Eric E. Schmidt, O.D. Omni Eye Specialists Wilmington, NC schmidtyvision@msn.com Points To Live By 25% of G pxs NEVER have IOP >21mm 50% of G pxs have trough
More information3/31/2019. Role of IOP. Role of IOP. Role of IOP. Role of IOP. Evaluation of glaucoma has changed Why hasn t treatment?
Glaucoma Update ROLE FOR RHOPRESSA Gregory D. Searcy, M.D. 1857: German ophthalmologist Albrecht Van Graefe concluded all glaucomatous optic disc excavation is associated with high IOP based on the only
More informationDiurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension.
Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Bengtsson, Boel; Heijl, Anders Published in: Graefe's Archive for Clinical and
More informationTargeting Intraocular Pressure in Glaucoma: a Teaching Case Report 1
Targeting Intraocular Pressure in Glaucoma: a Teaching Case Report 1 By: Andrew Kemp, OD, Marcus Gonzales, OD, FAAO, Joe DeLoach, OD, FAAO, and Zanna Kruoch, OD FAAO Background Glaucoma is a range of conditions
More informationGoals. Glaucoma PARA PEARL TO DO. Vision Loss with Glaucoma
Glaucoma Janet R. Fett, OD Drs. Kincaid, Fett and Tharp So Sioux City, NE eyewear21@hotmail.com Goals Understand Glaucoma Disease process Understand how your data (objective and subjective) assists in
More information24-h Efficacy of Glaucoma Treatment Options
Adv Ther (2016) 33:481 517 DOI 10.1007/s12325-016-0302-0 REVIEW 24-h Efficacy of Glaucoma Treatment Options Anastasios G. P. Konstas. Luciano Quaranta. Banu Bozkurt. Andreas Katsanos. Julian Garcia-Feijoo.
More informationNoel de Jesus Atienza, MD, MSc and Joseph Anthony Tumbocon, MD
Original Article Philippine Journal of OPHTHALMOLOGY Diagnostic Accuracy of the Optical Coherence Tomography in Assessing Glaucoma Among Filipinos. Part 1: Categorical Outcomes Based on a Normative Database
More informationeffect of previous argon laser trabeculoplasty
Graefe s Arch Clin Exp Ophthalmol (2006) 244: 1073 1076 CLINICAL INVESTIGATION DOI 10.1007/s00417-005-0198-x Esther Arranz-Marquez Miguel A. Teus Effect of previous argon laser trabeculoplasty on the ocular
More informationRetinal Nerve Fiber Layer Measurements in Myopia Using Optical Coherence Tomography
Original Article Philippine Journal of OPHTHALMOLOGY Retinal Nerve Fiber Layer Measurements in Myopia Using Optical Coherence Tomography Dennis L. del Rosario, MD and Mario M. Yatco, MD University of Santo
More informationLong Term Efficacy of Repeat Treatment with SLT: Seven Years Follow up
Long Term Efficacy of Repeat Treatment with SLT: Seven Years Follow up Lawrence F. Jindra, MD Columbia University Winthrop University Hospital Disclosure Speaker has independently conducted and financed
More informationWritten by Administrator Wednesday, 13 January :27 - Last Updated Thursday, 21 January :34
angle closure glaucoma A type of glaucoma caused by a sudden and severe rise in eye pressure. Occurs when the pupil enlarges too much or too quickly, and the outer edge of the iris blocks the eye s drainage
More information24-hour Intraocular Pressure and Ocular Perfusion Pressure in Glaucoma
SURVEY OF OPHTHALMOLOGY VOLUME 58 NUMBER 1 JANUARY FEBRUARY 2013 MAJOR REVIEW 24-hour Intraocular Pressure and Ocular Perfusion Pressure in Glaucoma Luciano Quaranta, MD, PhD, 1 Andreas Katsanos, MD, PhD,
More informationA Review Of Risk Factors. Early Detection Of Glaucoma Clinical Clues. A risk factor analysis is critical. Points To Live By
A Review Of Risk Factors Early Detection Of Glaucoma Clinical Clues Eric E. Schmidt, O.D. Omni Eye Specialists Wilmington, NC schmidtyvision@msn.com FINDACAR Family history IOP Nearsightedness Diabetes/Vascular
More informationThe evaluation of retinal nerve fiber layer in pigment dispersion syndrome and pigmentary glaucoma using scanning laser polarimetry
European Journal of Ophthalmology / Vol. 13 no. 4, 2003 / pp. 377-382 The evaluation of retinal nerve fiber layer in pigment dispersion syndrome and pigmentary glaucoma using scanning laser polarimetry
More informationThe overall rate of decrease in visual field sensitivity in
Glaucoma Estimating the True Distribution of Visual Field Progression Rates in Glaucoma Andrew J. Anderson Department of Optometry and Vision Sciences, The University of Melbourne, Parkville, Australia
More informationClinical decision making based on data from GDx: One year observations
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2002 Clinical decision making based on data from GDx: One year observations James C. Bobrow Washington University
More informationGLAUCOMA SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES
SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES Introduction These are summary benchmarks for the Academy s Preferred Practice Pattern (PPP) guidelines. The Preferred Practice Pattern series
More informationPractical approach to medical management of glaucoma DR. RATHINI LILIAN DAVID
Practical approach to medical management of glaucoma DR. RATHINI LILIAN DAVID Glaucoma is one of the major causes of visual loss worldwide. The philosophy of glaucoma management is to preserve the visual
More informationCollaboration in the care of glaucoma patients and glaucoma suspects. Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012
Collaboration in the care of glaucoma patients and glaucoma suspects Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012 Goals of Collaboration Patient-centred and evidence based approach Timely access
More informationMacular Ganglion Cell Complex Measurement Using Spectral Domain Optical Coherence Tomography in Glaucoma
Med. J. Cairo Univ., Vol. 83, No. 2, September: 67-72, 2015 www.medicaljournalofcairouniversity.net Macular Ganglion Cell Complex Measurement Using Spectral Domain Optical Coherence Tomography in Glaucoma
More informationRetinal nerve fiber layer thickness in Indian eyes with optical coherence tomography
Original articles in Indian eyes with optical coherence tomography Malik A, Singh M, Arya SK, Sood S, Ichhpujani P Department of Ophthalmology Government Medical College and Hospital, Sector 32, Chandigarh,
More informationComparison of Retinal Nerve Fiber Layer Thickness between Stratus and Spectralis OCT
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2011;25(3):166-173 DOI: 10.3341/kjo.2011.25.3.166 Original Article Comparison of Retinal Nerve Fiber Layer Thickness between Stratus and Spectralis
More informationA genetic basis has been postulated for
Intraocular pressure response to topical corticosteroids Bernard Becker The intraocular pressure response to topical betamethasone appears to be genetically determined. A study of patients with primary
More informationFluctuation of Intraocular Pressure and Glaucoma Progression in the Early Manifest Glaucoma Trial
Fluctuation of Intraocular Pressure and Glaucoma Progression in the Early Manifest Glaucoma Trial Boel Bengtsson, PhD, 1 M. Cristina Leske, MD, MPH, 2 Leslie Hyman, PhD, 2 Anders Heijl, MD, PhD, 1 Early
More informationGlaucoma. Glaucoma. Optic Disc Cupping
Glaucoma What is Glaucoma? Bruce James A group of diseases in which damage to the optic nerve occurs as a result of intraocualar pressure being above the physiological norm for that eye Stoke Mandeville
More informationPresent relevant clinical findings of four landmark glaucoma trials OHTS, EMGT, CNTGS and CIGTS.
Course title: The Glaucoma Compass Course length: 1 hour +/- 31 slides Corse Description: Even with the technology and available information, glaucoma decision making can still be confusing. How should
More informationM Diestelhorst, L-I Larsson,* for The European Latanoprost Fixed Combination Study Group...
199 SCIENTIFIC REPORT A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension
More informationMEDICAL POLICY SUBJECT: CORNEAL ULTRASOUND PACHYMETRY. POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: CORNEAL ULTRASOUND,, PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationResearch Article Long-Term Clinical Course of Normal-Tension Glaucoma: 20 Years of Experience
Hindawi Ophthalmology Volume 2017, Article ID 2651645, 6 pages https://doi.org/10.1155/2017/2651645 Research Article Long-Term Clinical Course of Normal-Tension Glaucoma: 20 Years of Experience Sang Wook
More informationCLINICAL SCIENCES. Steven L. Mansberger, MD; Pamela A. Sample, PhD; Linda Zangwill, PhD; Robert N. Weinreb, MD
CLINICAL SCIENCES Achromatic and Short-Wavelength Automated Perimetry in Patients With Glaucomatous Large Cups Steven L. Mansberger, MD; Pamela A. Sample, PhD; Linda Zangwill, PhD; Robert N. Weinreb, MD
More informationA comparison of HRT II and GDx imaging for glaucoma detection in a primary care eye clinic setting
(2007) 21, 1050 1055 & 2007 Nature Publishing Group All rights reserved 0950-222X/07 $30.00 www.nature.com/eye CLINICAL STUDY A comparison of HRT II and GDx imaging for glaucoma detection in a primary
More informationIs Posner Schlossman Syndrome Benign?
Is Posner Schlossman Syndrome Benign? Aliza Jap, FRCS (G), 1 Meenakshi Sivakumar, FRCS (Ed), M Med (Ophth), 2, Soon-Phaik Chee, FRCS (Ed), FRCOphth 2 Purpose: To determine the clinical course of patients
More informationGlaucoma Clinical Update. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012
Glaucoma Clinical Update Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012 Objectives Understand the different categories of glaucoma Recognize the symptoms and signs of open angle and angle-closure
More informationBehandlungsstrategien beim Offenwinkelglaukom. F. Bochmann, Augenklinik LUKS
Behandlungsstrategien beim Offenwinkelglaukom F. Bochmann, Augenklinik LUKS What is strategy? what is our goal? where are we? how can we achieve our goal? Mission Statement The goal of glaucoma management
More informationThe Utility of the Monocular Trial
The Utility of the Monocular Trial Data from the Ocular Hypertension Treatment Study Anjali M. Bhorade, MD, MSCI, 1 Bradley S. Wilson, MA, 1 Mae O. Gordon, PhD, 1 Paul Palmberg, MD, PhD, 2 Robert N. Weinreb,
More informationEfficacy of latanoprost in management of chronic angle closure glaucoma. Kumar S 1, Malik A 2 Singh M 3, Sood S 4. Abstract
Original article Efficacy of latanoprost in management of chronic angle closure glaucoma Kumar S 1, Malik A 2 Singh M 3, Sood S 4 1 Associate Professor, 2 Assistant Professor, 4 Professor, Department of
More informationScanning laser polarimetry (SLP) provides real-time, objective
The Effect of Atypical Birefringence Patterns on Glaucoma Detection Using Scanning Laser Polarimetry with Variable Corneal Compensation Christopher Bowd, Felipe A. Medeiros, Robert N. Weinreb, and Linda
More informationC-reactive Protein and Lipid Profiles in Korean Patients With Normal Tension Glaucoma
접수번호 : 2008-099 Korean Journal of Ophthalmology 2009;23:193-197 ISSN : 1011-8942 DOI : 10.3341/kjo.2009.23.3.193 C-reactive Protein and Lipid Profiles in Korean Patients With Normal Tension Glaucoma Jaewan
More informationReproducibility of Nerve Fiber Layer Thickness Measurements by Use of Optical Coherence Tomography
Reproducibility of Nerve Fiber Layer Thickness Measurements by Use of Optical Coherence Tomography Eytan Z. Blumenthal, MD, 1 Julia M. Williams, BS, 1 Robert N. Weinreb, MD, 1 Christopher A. Girkin, MD,
More informationCentral Corneal Thickness-An important variable for prognostication in Primary Open Angle glaucoma; A Kolkata based study in Eastern India
Original article: Central Corneal Thickness-An important variable for prognostication in Primary Open Angle glaucoma; A Kolkata based study in Eastern India 1Dr. Apala Bhattacharya, 2 Dr Gautam Bhaduri,
More informationS Morishita, T Tanabe, S Yu, M Hangai, T Ojima, H Aikawa, N Yoshimura. Clinical science
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan Correspondence to: Dr T Tanabe, Department of Ophthalmology, The Tazuke Kofukai Medical Institute,
More information1/31/2018. Course Objectives. Diagnostic Testing. Optic Nerve Damage ANATOMY AND PHYSIOLOGY OF A GLAUCOMA WORK-UP/TONOMETRY TECHNICIAN: -SDP
ANATOMY AND PHYSIOLOGY OF A GLAUCOMA WORK-UP/TONOMETRY KNOW THE DISEASE PROCESS TECHNICIAN: EXPLAIN PROCESS OF EXAMINATION Presenters: Dana McMahan, COA Nicole Smith, COA Engage with patient s, help alleviate
More informationCorrelation of Blue Chromatic Macular Sensitivity with Optic Disc Change in Early Glaucoma Patients
Correlation of Blue Chromatic Macular Sensitivity with Optic Disc Change in Early Glaucoma Patients Yoshio Yamazaki, Kenji Mizuki, Fukuko Hayamizu and Chizuru Tanaka Department of Ophthalmology, Nihon
More informationAvailable online at Pelagia Research Library. Advances in Applied Science Research, 2013, 4(6):
Available online at www.pelagiaresearchlibrary.com Advances in Applied Science Research, 2013, 4(6):201-206 ISSN: 0976-8610 CODEN (USA): AASRFC Comparison of glaucoma diagnostic ability of retinal nerve
More informationDetection of Glaucoma Using Scanning Laser Polarimetry with Enhanced Corneal Compensation
Detection of Glaucoma Using Scanning Laser Polarimetry with Enhanced Corneal Compensation Felipe A. Medeiros, Christopher Bowd, Linda M. Zangwill, Chirag Patel, and Robert N. Weinreb From the Hamilton
More informationCorrelating Structure With Function in End-Stage Glaucoma
C L I N I C A L S C I E N C E Correlating Structure With Function in End-Stage Glaucoma Eytan Z. Blumenthal, MD; Amjad Horani, MD; Rajesh Sasikumar, MD; Chandrasekhar Garudadri, MD; Addepalli Udaykumar,
More informationMicro-Invasive Glaucoma Surgery (Aqueous Stents)
Micro-Invasive Glaucoma Surgery (Aqueous Stents) Policy Number: Original Effective Date: MM.06.029 02/01/2019 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 02/01/2019 Section:
More informationGlaucoma: Diagnostic Modalities
Glaucoma: Diagnostic Modalities - Dr. Barun Kumar Nayak, Dr. Sarika Ramugade Glaucoma is a leading cause of blindness in the world, especially in older people. Early detection and treatment by ophthalmologist
More informationCLINICAL SCIENCES. Validation of a Predictive Model to Estimate the Risk of Conversion From Ocular Hypertension to Glaucoma
CLINICAL SCIENCES Validation of a Predictive Model to Estimate the Risk of Conversion From Ocular Hypertension to Glaucoma Felipe A. Medeiros, MD; Robert N. Weinreb, MD; Pamela A. Sample, PhD; Cintia F.
More informationTo assess the glaucoma diagnostic ability of Fourier Domain Optical Coherence Tomography
American Journal of Engineering Research (AJER) e-issn : 2320-0847 p-issn : 2320-0936 Volume-02, Issue-11, pp-104-110 www.ajer.org Research Paper Open Access To assess the glaucoma diagnostic ability of
More informationCLINICAL SCIENCES. Aqueous Humor Dynamics During the Day and Night in Healthy Mature Volunteers
CLINICAL SCIENCES Aqueous Humor Dynamics During the Day and Night in Healthy Mature Volunteers Hong Liu, MD, PhD; Shan Fan, MD; Vikas Gulati, MD; Lucinda J. Camras, BS; Guilin Zhan, MD; Deepta Ghate, MD;
More informationThe Uniocular Drug Trial and Second-Eye Response to Glaucoma Medications
The Uniocular Drug Trial and Second-Eye Response to Glaucoma Medications Tony Realini, MD, 1 Robert D. Fechtner, MD, 2 Sean-Paul Atreides, MD, 3 Stephen Gollance, MD 2 Purpose: To determine if the intraocular
More informationMicro-Invasive Glaucoma Surgery (Aqueous Stents)
Micro-Invasive Glaucoma Surgery (Aqueous Stents) Policy Number: Original Effective Date: MM.06.029 02/01/2019 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 02/01/2019 Section:
More informationClinical Research in Glaucoma
Clinical Research in Glaucoma J. James Thimons, O.D., FAAO Chairman, National Glaucoma Society www.nationalglaucomasociety.org Ocular Hypertension Treatment Study (OHTS) Primary Goals Evaluate the safety
More informationIncorporating Risk Factors to Improve the Assessment of Rates of Glaucomatous Progression
Glaucoma Incorporating Risk Factors to Improve the Assessment of Rates of Glaucomatous Progression Felipe A. Medeiros, Linda M. Zangwill, Kaweh Mansouri, Renato Lisboa, Ali Tafreshi, and Robert N. Weinreb
More informationPatterns of Subsequent Progression of Localized Retinal Nerve Fiber Layer Defects on Red-free Fundus Photographs in Normal-tension Glaucoma
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2014;28(4):330-336 http://dx.doi.org/10.3341/kjo.2014.28.4.330 Original Article Patterns of Subsequent Progression of Localized Retinal Nerve Fiber
More informationSensitivity and specificity of new GDx parameters Colen TP, Tang NEML, Mulder PGH and Lemij HG Submitted for publication CHAPTER 7
Sensitivity and specificity of new GDx parameters Colen TP, Tang NEML, Mulder PGH and Lemij HG Submitted for publication CHAPTER 7 61 Abstract Purpose The GDx is a scanning laser polarimeter that assesses
More informationPREVALENCE OF GLAUCOMA AMONG FISHERMEN COMMUNITY OF MUNDRA TALUKA OF KUTCH DISTRICT- A CROSS- SECTIONAL STUDY
ORIGINAL RESEARCH PREVALENCE OF GLAUCOMA AMONG FISHERMEN COMMUNITY OF MUNDRA TALUKA OF KUTCH DISTRICT- A CROSS- SECTIONAL STUDY Sanjay Upadhyay 1, Jayantilal Shah 2 1 Assistant Professor, 2 Associate Professor,
More informationOptic disc damage has been shown to precede visual field
Confocal Scanning Laser Ophthalmoscopy Classifiers and Stereophotograph Evaluation for rediction of Visual Field Abnormalities in Glaucoma-Suspect Eyes Christopher Bowd, 1 Linda M. Zangwill, 1 Felipe A.
More informationUnderstanding Angle Closure
Case Understanding Angle Closure Dominick L. Opitz, OD, FAAO Associate Professor Illinois College of Optometry 56 year old Caucasian Male Primary Eye Exam BCVA: 20/25 OD with+1.25 DS 20/25 OS with +1.75
More informationPRACTICAL APPROACH TO MEDICAL MANAGEMENT OF GLAUCOMA
PRACTICAL APPROACH TO MEDICAL MANAGEMENT OF GLAUCOMA DR. RAVI THOMAS, DR. RAJUL PARIKH, DR. SHEFALI PARIKH IJO MAY 2008 PRESENTER AT JDOS : DR. RAHUL SHUKLA T.N. SHUKLA EYE HOSPITAL TERMINOLOGY POAG: PRIMARY
More informationCorrelation and agreement between the 24-hour diurnal tension curve, the water-drinking test, and the postural-change test in glaucoma patients*
Journal for Modeling in Ophthalmology 2017; 3:47-59 Original article Correlation and agreement between the 24-hour diurnal tension curve, the water-drinking test, and the postural-change test in glaucoma
More informationScanning Laser Tomography to Evaluate Optic Discs of Normal Eyes
Scanning Laser Tomography to Evaluate Optic Discs of Normal Eyes Hiroshi Nakamura,* Toshine Maeda,* Yasuyuki Suzuki and Yoichi Inoue* *Eye Division of Olympia Medical Clinic, Tokyo, Japan; Department of
More informationAbility of Scanning Laser Polarimetry (GDx) to Discriminate among Early Glaucomatous, Ocular Hypertensive and Normal Eyes in the Korean Population
Korean J Ophthalmol Vol. 18:1-8, 2004 Ability of Scanning Laser Polarimetry (GDx) to Discriminate among Early Glaucomatous, Ocular Hypertensive and Normal Eyes in the Korean Population Sun Young Lee, MD,
More informationGLAUCOMA. An Overview
GLAUCOMA An Overview Compiled by Campbell M Gold (2004) CMG Archives http://campbellmgold.com --()-- IMPORTANT The health information contained herein is not meant as a substitute for advice from your
More informationINTRODUCTION S. HERDENER, D. HAFIZOVIC, M. PACHE, S. LAUTEBACH, J. FUNK. University Eye Hospital, Freiburg - Germany
European Journal of Ophthalmology / Vol. 18 no. 1, 2008 / pp. 39-43 Is the PASCAL -Tonometer suitable for measuring intraocular pressure in clinical routine? Long- and short-term reproducibility of dynamic
More informationDetection of Progressive Retinal Nerve Fiber Layer Loss in Glaucoma Using Scanning Laser Polarimetry with Variable Corneal Compensation
Detection of Progressive Retinal Nerve Fiber Layer Loss in Glaucoma Using Scanning Laser Polarimetry with Variable Corneal Compensation Felipe A. Medeiros, Luciana M. Alencar, Linda M. Zangwill, Christopher
More informationMethod for comparing visual field defects to local RNFL and RGC damage seen on frequency domain OCT in patients with glaucoma.
Method for comparing visual field defects to local RNFL and RGC damage seen on frequency domain OCT in patients with glaucoma. Donald C. Hood 1,2,* and Ali S. Raza 1 1 Department of Psychology, Columbia
More informationFinancial Disclosure. Visual Field Interpretation RELIABILITY VISUAL FIELD INTERPRETATION IN GLAUCOMA METHODS OF DATA PRESENTATION
VISUAL FIELD INTERPRETATION IN GLAUCOMA Danica J. Marrelli, OD, FAAO University of Houston College of Optometry Financial Disclosure I have received speaking and/or consulting fees from: Aerie Pharmaceutical
More information9/25/2017 CASE. 67 years old On 2 topical meds since 3 years. Rx: +3.0 RE LE
CASE 67 years old On 2 topical meds since 3 years Rx: +3.0 /-0.5@65 RE +2.5/-0.5@115 LE IOP : 17 RE 19 LE CD: 0.5 RE 0.6 LE 1 67 years old On 2 topical meds since 3 years Rx: +3.0 /-0.5@65 RE +2.5/-0.5@115
More informationCorporate Medical Policy
Corporate Medical Policy Glaucoma, Evaluation by Ophthalmologic Techniques File Name: Origination: Last CAP Review: Next CAP Review: Last Review: glaucoma_evaluation_by_ophthalmologic_techniques 3/2001
More informationInvestigation of the relationship between central corneal thickness and retinal nerve fiber layer thickness in ocular hypertension
Acta Medica Anatolia Volume 2 Issue 1 2014 Investigation of the relationship between central corneal thickness and retinal nerve fiber layer thickness in ocular hypertension Remzi Mısır 1, Sinan Sarıcaoğlu
More informationMake a more confident glaucoma risk assessment with Corneal Hysteresis, a superior predictor of glaucoma progression.
Make a more confident glaucoma risk assessment with Corneal Hysteresis, a superior predictor of glaucoma progression. Advancing Eye Care. American Innovation. Reichert Ocular Response Analyzer G3. Make
More informationClinical Study Visual Field Loss Morphology in High- and Normal-Tension Glaucoma
Journal of Ophthalmology Volume 2012, Article ID 327326, 8 pages doi:10.1155/2012/327326 Clinical Study Visual Field Loss Morphology in High- and Normal-Tension Glaucoma Michele Iester, 1, 2 Fabio De Feo,
More informationClinical Profile of Primary Open Angle Glaucoma Suspects.
DOI: 10.21276/aimdr.2018.4.2.OT3 Original Article ISSN (O):2395-2822; ISSN (P):2395-2814 Clinical Profile of Primary Open Angle Glaucoma Suspects. Pradnya Abhinav Mohan 1 1 Fellow Phaco-surgery, Department
More informationPooling Data from Similar Randomized Clinical Trials Comparing Latanoprost with Timolol; Medical Results and Statistical Aspects
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1235 Pooling Data from Similar Randomized Clinical Trials Comparing Latanoprost with Timolol; Medical Results and Statistical
More informationCLINICAL SCIENCES. Comparison of Glaucoma Diagnostic Capabilities of Cirrus HD and Stratus Optical Coherence Tomography
CLINICAL SCIENCES Comparison of Glaucoma Diagnostic Capabilities of Cirrus HD and Stratus Optical Coherence Tomography Seong Bae Park, MD; Kyung Rim Sung, MD, PhD; Sung Yong Kang, MD; Kyung Ri Kim, BS;
More informationDiscrimination between normal and glaucomatous eyes with visual field and scanning laser polarimetry measurements
586 Glaucoma Service, Department of Ophthalmology, University of Campinas, Campinas, Brazil R Lauande-Pimentel R A Carvalho H C Oliveira D C Gonçalves L M Silva V P Costa Glaucoma Service, Department of
More informationCorrelating central corneal thickness and intraocular pressure in ocular hypertension and glaucoma
VOL. 3 NO. 1 PHILIPPINE JOURNAL OF Ophthalmology JANUARY ORIGINAL ARTICLE JUNE 07 Jonathan G. Soriano, MD 1 Ma. Margarita L. Lat-Luna, MD 1, 3 Patricia M. Khu, MD 1, 1 Department of Ophthalmology and Visual
More informationPeretyagin O.A., Cand. Med. Sc., Ass. Prof.; Dmitriev S.K., Dr. Med. Sc., Prof.; Lazar Yu.M., Cand. Med. Sc.; Tatarina Yu.A., Junior Research Fellow
Changes in corneoscleral rigidity and corneal thickness at various target intraocular pressures in patients with stabilized primary open-angle glaucoma Peretyagin O.A., Cand. Med. Sc., Ass. Prof.; Dmitriev
More information